nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP3A7—Ifosfamide—testicular cancer	0.121	0.185	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.121	0.185	CbGbCtD
Aprepitant—CYP3A5—Ifosfamide—testicular cancer	0.0904	0.139	CbGbCtD
Aprepitant—CYP2C19—Ifosfamide—testicular cancer	0.0729	0.112	CbGbCtD
Aprepitant—CYP2C9—Ifosfamide—testicular cancer	0.0606	0.093	CbGbCtD
Aprepitant—CYP3A5—Etoposide—testicular cancer	0.0432	0.0663	CbGbCtD
Aprepitant—CYP3A4—Ifosfamide—testicular cancer	0.0353	0.0541	CbGbCtD
Aprepitant—CYP1A2—Etoposide—testicular cancer	0.0322	0.0493	CbGbCtD
Aprepitant—CYP2C9—Cisplatin—testicular cancer	0.0295	0.0452	CbGbCtD
Aprepitant—CYP3A4—Vinblastine—testicular cancer	0.0187	0.0287	CbGbCtD
Aprepitant—CYP3A4—Etoposide—testicular cancer	0.0168	0.0258	CbGbCtD
Aprepitant—CYP3A4—Doxorubicin—testicular cancer	0.0115	0.0176	CbGbCtD
Aprepitant—Feeling abnormal—Etoposide—testicular cancer	0.000213	0.000612	CcSEcCtD
Aprepitant—Hyperglycaemia—Doxorubicin—testicular cancer	0.000213	0.000611	CcSEcCtD
Aprepitant—Nausea—Dactinomycin—testicular cancer	0.000212	0.00061	CcSEcCtD
Aprepitant—Pneumonia—Doxorubicin—testicular cancer	0.000211	0.000608	CcSEcCtD
Aprepitant—Gastrointestinal pain—Etoposide—testicular cancer	0.000211	0.000608	CcSEcCtD
Aprepitant—Infestation NOS—Doxorubicin—testicular cancer	0.00021	0.000604	CcSEcCtD
Aprepitant—Infestation—Doxorubicin—testicular cancer	0.00021	0.000604	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000208	0.000599	CcSEcCtD
Aprepitant—Vomiting—Ifosfamide—testicular cancer	0.000208	0.000598	CcSEcCtD
Aprepitant—Hypersensitivity—Cisplatin—testicular cancer	0.000208	0.000597	CcSEcCtD
Aprepitant—Bradycardia—Epirubicin—testicular cancer	0.000208	0.000597	CcSEcCtD
Aprepitant—Renal failure—Doxorubicin—testicular cancer	0.000207	0.000594	CcSEcCtD
Aprepitant—Rash—Ifosfamide—testicular cancer	0.000206	0.000593	CcSEcCtD
Aprepitant—Dermatitis—Ifosfamide—testicular cancer	0.000206	0.000593	CcSEcCtD
Aprepitant—Erythema multiforme—Methotrexate—testicular cancer	0.000206	0.000592	CcSEcCtD
Aprepitant—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000206	0.000592	CcSEcCtD
Aprepitant—Urticaria—Etoposide—testicular cancer	0.000205	0.00059	CcSEcCtD
Aprepitant—Stomatitis—Doxorubicin—testicular cancer	0.000205	0.000589	CcSEcCtD
Aprepitant—Abdominal pain—Etoposide—testicular cancer	0.000204	0.000587	CcSEcCtD
Aprepitant—Body temperature increased—Etoposide—testicular cancer	0.000204	0.000587	CcSEcCtD
Aprepitant—Urinary tract infection—Doxorubicin—testicular cancer	0.000204	0.000587	CcSEcCtD
Aprepitant—Conjunctivitis—Doxorubicin—testicular cancer	0.000204	0.000587	CcSEcCtD
Aprepitant—Eye disorder—Methotrexate—testicular cancer	0.000204	0.000585	CcSEcCtD
Aprepitant—Tinnitus—Methotrexate—testicular cancer	0.000203	0.000584	CcSEcCtD
Aprepitant—Hypoaesthesia—Epirubicin—testicular cancer	0.000203	0.000583	CcSEcCtD
Aprepitant—Asthenia—Cisplatin—testicular cancer	0.000202	0.000582	CcSEcCtD
Aprepitant—Pharyngitis—Epirubicin—testicular cancer	0.000202	0.000582	CcSEcCtD
Aprepitant—Cardiac disorder—Methotrexate—testicular cancer	0.000202	0.000581	CcSEcCtD
Aprepitant—Urinary tract disorder—Epirubicin—testicular cancer	0.000201	0.000579	CcSEcCtD
Aprepitant—Haematuria—Doxorubicin—testicular cancer	0.0002	0.000576	CcSEcCtD
Aprepitant—Connective tissue disorder—Epirubicin—testicular cancer	0.0002	0.000576	CcSEcCtD
Aprepitant—Urethral disorder—Epirubicin—testicular cancer	0.0002	0.000575	CcSEcCtD
Aprepitant—Angiopathy—Methotrexate—testicular cancer	0.000198	0.000568	CcSEcCtD
Aprepitant—Immune system disorder—Methotrexate—testicular cancer	0.000197	0.000566	CcSEcCtD
Aprepitant—Mediastinal disorder—Methotrexate—testicular cancer	0.000196	0.000565	CcSEcCtD
Aprepitant—Chills—Methotrexate—testicular cancer	0.000195	0.000562	CcSEcCtD
Aprepitant—Nausea—Ifosfamide—testicular cancer	0.000194	0.000559	CcSEcCtD
Aprepitant—Diarrhoea—Cisplatin—testicular cancer	0.000193	0.000555	CcSEcCtD
Aprepitant—Erythema multiforme—Epirubicin—testicular cancer	0.000193	0.000554	CcSEcCtD
Aprepitant—Alopecia—Methotrexate—testicular cancer	0.000193	0.000554	CcSEcCtD
Aprepitant—Bradycardia—Doxorubicin—testicular cancer	0.000192	0.000552	CcSEcCtD
Aprepitant—Mental disorder—Methotrexate—testicular cancer	0.000191	0.000549	CcSEcCtD
Aprepitant—Eye disorder—Epirubicin—testicular cancer	0.000191	0.000548	CcSEcCtD
Aprepitant—Hypersensitivity—Etoposide—testicular cancer	0.00019	0.000547	CcSEcCtD
Aprepitant—Tinnitus—Epirubicin—testicular cancer	0.00019	0.000547	CcSEcCtD
Aprepitant—Erythema—Methotrexate—testicular cancer	0.00019	0.000545	CcSEcCtD
Aprepitant—Malnutrition—Methotrexate—testicular cancer	0.00019	0.000545	CcSEcCtD
Aprepitant—Flushing—Epirubicin—testicular cancer	0.000189	0.000544	CcSEcCtD
Aprepitant—Cardiac disorder—Epirubicin—testicular cancer	0.000189	0.000544	CcSEcCtD
Aprepitant—Hypoaesthesia—Doxorubicin—testicular cancer	0.000188	0.00054	CcSEcCtD
Aprepitant—Pharyngitis—Doxorubicin—testicular cancer	0.000187	0.000538	CcSEcCtD
Aprepitant—Urinary tract disorder—Doxorubicin—testicular cancer	0.000186	0.000536	CcSEcCtD
Aprepitant—Dysgeusia—Methotrexate—testicular cancer	0.000186	0.000534	CcSEcCtD
Aprepitant—Asthenia—Etoposide—testicular cancer	0.000185	0.000533	CcSEcCtD
Aprepitant—Connective tissue disorder—Doxorubicin—testicular cancer	0.000185	0.000533	CcSEcCtD
Aprepitant—Angiopathy—Epirubicin—testicular cancer	0.000185	0.000532	CcSEcCtD
Aprepitant—Urethral disorder—Doxorubicin—testicular cancer	0.000185	0.000532	CcSEcCtD
Aprepitant—Immune system disorder—Epirubicin—testicular cancer	0.000184	0.000529	CcSEcCtD
Aprepitant—Mediastinal disorder—Epirubicin—testicular cancer	0.000184	0.000528	CcSEcCtD
Aprepitant—Back pain—Methotrexate—testicular cancer	0.000183	0.000527	CcSEcCtD
Aprepitant—Chills—Epirubicin—testicular cancer	0.000183	0.000526	CcSEcCtD
Aprepitant—Pruritus—Etoposide—testicular cancer	0.000183	0.000526	CcSEcCtD
Aprepitant—Alopecia—Epirubicin—testicular cancer	0.00018	0.000518	CcSEcCtD
Aprepitant—Vomiting—Cisplatin—testicular cancer	0.000179	0.000516	CcSEcCtD
Aprepitant—Mental disorder—Epirubicin—testicular cancer	0.000179	0.000514	CcSEcCtD
Aprepitant—Erythema multiforme—Doxorubicin—testicular cancer	0.000178	0.000513	CcSEcCtD
Aprepitant—Rash—Cisplatin—testicular cancer	0.000178	0.000511	CcSEcCtD
Aprepitant—Dermatitis—Cisplatin—testicular cancer	0.000178	0.000511	CcSEcCtD
Aprepitant—Malnutrition—Epirubicin—testicular cancer	0.000177	0.00051	CcSEcCtD
Aprepitant—Erythema—Epirubicin—testicular cancer	0.000177	0.00051	CcSEcCtD
Aprepitant—Diarrhoea—Etoposide—testicular cancer	0.000177	0.000508	CcSEcCtD
Aprepitant—Eye disorder—Doxorubicin—testicular cancer	0.000176	0.000507	CcSEcCtD
Aprepitant—Ill-defined disorder—Methotrexate—testicular cancer	0.000176	0.000506	CcSEcCtD
Aprepitant—Tinnitus—Doxorubicin—testicular cancer	0.000176	0.000506	CcSEcCtD
Aprepitant—Anaemia—Methotrexate—testicular cancer	0.000175	0.000504	CcSEcCtD
Aprepitant—Flushing—Doxorubicin—testicular cancer	0.000175	0.000503	CcSEcCtD
Aprepitant—Cardiac disorder—Doxorubicin—testicular cancer	0.000175	0.000503	CcSEcCtD
Aprepitant—Flatulence—Epirubicin—testicular cancer	0.000175	0.000503	CcSEcCtD
Aprepitant—Dysgeusia—Epirubicin—testicular cancer	0.000174	0.0005	CcSEcCtD
Aprepitant—Back pain—Epirubicin—testicular cancer	0.000172	0.000494	CcSEcCtD
Aprepitant—Angiopathy—Doxorubicin—testicular cancer	0.000171	0.000492	CcSEcCtD
Aprepitant—Malaise—Methotrexate—testicular cancer	0.000171	0.000492	CcSEcCtD
Aprepitant—Dizziness—Etoposide—testicular cancer	0.000171	0.000491	CcSEcCtD
Aprepitant—Muscle spasms—Epirubicin—testicular cancer	0.000171	0.000491	CcSEcCtD
Aprepitant—Immune system disorder—Doxorubicin—testicular cancer	0.00017	0.00049	CcSEcCtD
Aprepitant—Mediastinal disorder—Doxorubicin—testicular cancer	0.00017	0.000489	CcSEcCtD
Aprepitant—Chills—Doxorubicin—testicular cancer	0.000169	0.000487	CcSEcCtD
Aprepitant—Nausea—Cisplatin—testicular cancer	0.000168	0.000482	CcSEcCtD
Aprepitant—Alopecia—Doxorubicin—testicular cancer	0.000167	0.000479	CcSEcCtD
Aprepitant—Cough—Methotrexate—testicular cancer	0.000165	0.000476	CcSEcCtD
Aprepitant—Mental disorder—Doxorubicin—testicular cancer	0.000165	0.000475	CcSEcCtD
Aprepitant—Ill-defined disorder—Epirubicin—testicular cancer	0.000165	0.000473	CcSEcCtD
Aprepitant—Convulsion—Methotrexate—testicular cancer	0.000164	0.000472	CcSEcCtD
Aprepitant—Vomiting—Etoposide—testicular cancer	0.000164	0.000472	CcSEcCtD
Aprepitant—Malnutrition—Doxorubicin—testicular cancer	0.000164	0.000472	CcSEcCtD
Aprepitant—Erythema—Doxorubicin—testicular cancer	0.000164	0.000472	CcSEcCtD
Aprepitant—Anaemia—Epirubicin—testicular cancer	0.000164	0.000472	CcSEcCtD
Aprepitant—Rash—Etoposide—testicular cancer	0.000163	0.000468	CcSEcCtD
Aprepitant—Dermatitis—Etoposide—testicular cancer	0.000163	0.000468	CcSEcCtD
Aprepitant—Headache—Etoposide—testicular cancer	0.000162	0.000465	CcSEcCtD
Aprepitant—Flatulence—Doxorubicin—testicular cancer	0.000162	0.000465	CcSEcCtD
Aprepitant—Arthralgia—Methotrexate—testicular cancer	0.000161	0.000464	CcSEcCtD
Aprepitant—Chest pain—Methotrexate—testicular cancer	0.000161	0.000464	CcSEcCtD
Aprepitant—Myalgia—Methotrexate—testicular cancer	0.000161	0.000464	CcSEcCtD
Aprepitant—Dysgeusia—Doxorubicin—testicular cancer	0.000161	0.000462	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00016	0.000461	CcSEcCtD
Aprepitant—Malaise—Epirubicin—testicular cancer	0.00016	0.00046	CcSEcCtD
Aprepitant—Discomfort—Methotrexate—testicular cancer	0.00016	0.000459	CcSEcCtD
Aprepitant—Syncope—Epirubicin—testicular cancer	0.000159	0.000458	CcSEcCtD
Aprepitant—Back pain—Doxorubicin—testicular cancer	0.000159	0.000457	CcSEcCtD
Aprepitant—Muscle spasms—Doxorubicin—testicular cancer	0.000158	0.000454	CcSEcCtD
Aprepitant—Palpitations—Epirubicin—testicular cancer	0.000157	0.000451	CcSEcCtD
Aprepitant—Confusional state—Methotrexate—testicular cancer	0.000156	0.000449	CcSEcCtD
Aprepitant—Loss of consciousness—Epirubicin—testicular cancer	0.000156	0.000448	CcSEcCtD
Aprepitant—Cough—Epirubicin—testicular cancer	0.000155	0.000445	CcSEcCtD
Aprepitant—Anaphylactic shock—Methotrexate—testicular cancer	0.000155	0.000445	CcSEcCtD
Aprepitant—Convulsion—Epirubicin—testicular cancer	0.000154	0.000442	CcSEcCtD
Aprepitant—Infection—Methotrexate—testicular cancer	0.000154	0.000442	CcSEcCtD
Aprepitant—Nausea—Etoposide—testicular cancer	0.000153	0.000441	CcSEcCtD
Aprepitant—Hypertension—Epirubicin—testicular cancer	0.000153	0.000441	CcSEcCtD
Aprepitant—Ill-defined disorder—Doxorubicin—testicular cancer	0.000152	0.000438	CcSEcCtD
Aprepitant—Nervous system disorder—Methotrexate—testicular cancer	0.000152	0.000436	CcSEcCtD
Aprepitant—Anaemia—Doxorubicin—testicular cancer	0.000152	0.000436	CcSEcCtD
Aprepitant—Thrombocytopenia—Methotrexate—testicular cancer	0.000152	0.000436	CcSEcCtD
Aprepitant—Arthralgia—Epirubicin—testicular cancer	0.000151	0.000434	CcSEcCtD
Aprepitant—Chest pain—Epirubicin—testicular cancer	0.000151	0.000434	CcSEcCtD
Aprepitant—Myalgia—Epirubicin—testicular cancer	0.000151	0.000434	CcSEcCtD
Aprepitant—Anxiety—Epirubicin—testicular cancer	0.000151	0.000433	CcSEcCtD
Aprepitant—Skin disorder—Methotrexate—testicular cancer	0.00015	0.000432	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00015	0.000431	CcSEcCtD
Aprepitant—Hyperhidrosis—Methotrexate—testicular cancer	0.00015	0.00043	CcSEcCtD
Aprepitant—Discomfort—Epirubicin—testicular cancer	0.000149	0.000429	CcSEcCtD
Aprepitant—Malaise—Doxorubicin—testicular cancer	0.000148	0.000426	CcSEcCtD
Aprepitant—Dry mouth—Epirubicin—testicular cancer	0.000148	0.000425	CcSEcCtD
Aprepitant—Anorexia—Methotrexate—testicular cancer	0.000148	0.000424	CcSEcCtD
Aprepitant—Syncope—Doxorubicin—testicular cancer	0.000147	0.000423	CcSEcCtD
Aprepitant—Confusional state—Epirubicin—testicular cancer	0.000146	0.00042	CcSEcCtD
Aprepitant—Palpitations—Doxorubicin—testicular cancer	0.000145	0.000417	CcSEcCtD
Aprepitant—Oedema—Epirubicin—testicular cancer	0.000145	0.000416	CcSEcCtD
Aprepitant—Anaphylactic shock—Epirubicin—testicular cancer	0.000145	0.000416	CcSEcCtD
Aprepitant—Hypotension—Methotrexate—testicular cancer	0.000145	0.000416	CcSEcCtD
Aprepitant—Loss of consciousness—Doxorubicin—testicular cancer	0.000144	0.000415	CcSEcCtD
Aprepitant—Infection—Epirubicin—testicular cancer	0.000144	0.000414	CcSEcCtD
Aprepitant—Cough—Doxorubicin—testicular cancer	0.000143	0.000412	CcSEcCtD
Aprepitant—Shock—Epirubicin—testicular cancer	0.000143	0.00041	CcSEcCtD
Aprepitant—Convulsion—Doxorubicin—testicular cancer	0.000142	0.000409	CcSEcCtD
Aprepitant—Nervous system disorder—Epirubicin—testicular cancer	0.000142	0.000408	CcSEcCtD
Aprepitant—Thrombocytopenia—Epirubicin—testicular cancer	0.000142	0.000408	CcSEcCtD
Aprepitant—Hypertension—Doxorubicin—testicular cancer	0.000142	0.000408	CcSEcCtD
Aprepitant—Tachycardia—Epirubicin—testicular cancer	0.000141	0.000406	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000141	0.000405	CcSEcCtD
Aprepitant—Skin disorder—Epirubicin—testicular cancer	0.000141	0.000405	CcSEcCtD
Aprepitant—Hyperhidrosis—Epirubicin—testicular cancer	0.00014	0.000403	CcSEcCtD
Aprepitant—Insomnia—Methotrexate—testicular cancer	0.00014	0.000402	CcSEcCtD
Aprepitant—Chest pain—Doxorubicin—testicular cancer	0.00014	0.000402	CcSEcCtD
Aprepitant—Arthralgia—Doxorubicin—testicular cancer	0.00014	0.000402	CcSEcCtD
Aprepitant—Myalgia—Doxorubicin—testicular cancer	0.00014	0.000402	CcSEcCtD
Aprepitant—Anxiety—Doxorubicin—testicular cancer	0.000139	0.000401	CcSEcCtD
Aprepitant—Paraesthesia—Methotrexate—testicular cancer	0.000139	0.0004	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000139	0.000399	CcSEcCtD
Aprepitant—Discomfort—Doxorubicin—testicular cancer	0.000138	0.000397	CcSEcCtD
Aprepitant—Anorexia—Epirubicin—testicular cancer	0.000138	0.000397	CcSEcCtD
Aprepitant—Dyspnoea—Methotrexate—testicular cancer	0.000138	0.000397	CcSEcCtD
Aprepitant—Somnolence—Methotrexate—testicular cancer	0.000138	0.000396	CcSEcCtD
Aprepitant—Dry mouth—Doxorubicin—testicular cancer	0.000137	0.000393	CcSEcCtD
Aprepitant—Dyspepsia—Methotrexate—testicular cancer	0.000136	0.000392	CcSEcCtD
Aprepitant—Hypotension—Epirubicin—testicular cancer	0.000135	0.000389	CcSEcCtD
Aprepitant—Confusional state—Doxorubicin—testicular cancer	0.000135	0.000389	CcSEcCtD
Aprepitant—Decreased appetite—Methotrexate—testicular cancer	0.000135	0.000387	CcSEcCtD
Aprepitant—Anaphylactic shock—Doxorubicin—testicular cancer	0.000134	0.000385	CcSEcCtD
Aprepitant—Oedema—Doxorubicin—testicular cancer	0.000134	0.000385	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000134	0.000384	CcSEcCtD
Aprepitant—Fatigue—Methotrexate—testicular cancer	0.000133	0.000384	CcSEcCtD
Aprepitant—Infection—Doxorubicin—testicular cancer	0.000133	0.000383	CcSEcCtD
Aprepitant—Pain—Methotrexate—testicular cancer	0.000132	0.000381	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000132	0.000379	CcSEcCtD
Aprepitant—Shock—Doxorubicin—testicular cancer	0.000132	0.000379	CcSEcCtD
Aprepitant—Nervous system disorder—Doxorubicin—testicular cancer	0.000131	0.000378	CcSEcCtD
Aprepitant—Thrombocytopenia—Doxorubicin—testicular cancer	0.000131	0.000377	CcSEcCtD
Aprepitant—Insomnia—Epirubicin—testicular cancer	0.000131	0.000377	CcSEcCtD
Aprepitant—Tachycardia—Doxorubicin—testicular cancer	0.000131	0.000376	CcSEcCtD
Aprepitant—Skin disorder—Doxorubicin—testicular cancer	0.00013	0.000374	CcSEcCtD
Aprepitant—Paraesthesia—Epirubicin—testicular cancer	0.00013	0.000374	CcSEcCtD
Aprepitant—Hyperhidrosis—Doxorubicin—testicular cancer	0.00013	0.000373	CcSEcCtD
Aprepitant—Dyspnoea—Epirubicin—testicular cancer	0.000129	0.000371	CcSEcCtD
Aprepitant—Somnolence—Epirubicin—testicular cancer	0.000129	0.00037	CcSEcCtD
Aprepitant—Anorexia—Doxorubicin—testicular cancer	0.000128	0.000367	CcSEcCtD
Aprepitant—Feeling abnormal—Methotrexate—testicular cancer	0.000128	0.000367	CcSEcCtD
Aprepitant—Dyspepsia—Epirubicin—testicular cancer	0.000128	0.000367	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methotrexate—testicular cancer	0.000127	0.000364	CcSEcCtD
Aprepitant—Decreased appetite—Epirubicin—testicular cancer	0.000126	0.000362	CcSEcCtD
Aprepitant—Hypotension—Doxorubicin—testicular cancer	0.000125	0.00036	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000125	0.00036	CcSEcCtD
Aprepitant—Fatigue—Epirubicin—testicular cancer	0.000125	0.000359	CcSEcCtD
Aprepitant—Constipation—Epirubicin—testicular cancer	0.000124	0.000356	CcSEcCtD
Aprepitant—Pain—Epirubicin—testicular cancer	0.000124	0.000356	CcSEcCtD
Aprepitant—Urticaria—Methotrexate—testicular cancer	0.000123	0.000354	CcSEcCtD
Aprepitant—Body temperature increased—Methotrexate—testicular cancer	0.000122	0.000352	CcSEcCtD
Aprepitant—Abdominal pain—Methotrexate—testicular cancer	0.000122	0.000352	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000122	0.000351	CcSEcCtD
Aprepitant—Insomnia—Doxorubicin—testicular cancer	0.000121	0.000349	CcSEcCtD
Aprepitant—Paraesthesia—Doxorubicin—testicular cancer	0.00012	0.000346	CcSEcCtD
Aprepitant—Dyspnoea—Doxorubicin—testicular cancer	0.000119	0.000344	CcSEcCtD
Aprepitant—Feeling abnormal—Epirubicin—testicular cancer	0.000119	0.000343	CcSEcCtD
Aprepitant—Somnolence—Doxorubicin—testicular cancer	0.000119	0.000343	CcSEcCtD
Aprepitant—Gastrointestinal pain—Epirubicin—testicular cancer	0.000118	0.000341	CcSEcCtD
Aprepitant—Dyspepsia—Doxorubicin—testicular cancer	0.000118	0.000339	CcSEcCtD
Aprepitant—Decreased appetite—Doxorubicin—testicular cancer	0.000117	0.000335	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000116	0.000333	CcSEcCtD
Aprepitant—Fatigue—Doxorubicin—testicular cancer	0.000116	0.000332	CcSEcCtD
Aprepitant—Urticaria—Epirubicin—testicular cancer	0.000115	0.000331	CcSEcCtD
Aprepitant—Constipation—Doxorubicin—testicular cancer	0.000115	0.00033	CcSEcCtD
Aprepitant—Pain—Doxorubicin—testicular cancer	0.000115	0.00033	CcSEcCtD
Aprepitant—Body temperature increased—Epirubicin—testicular cancer	0.000115	0.000329	CcSEcCtD
Aprepitant—Abdominal pain—Epirubicin—testicular cancer	0.000115	0.000329	CcSEcCtD
Aprepitant—Hypersensitivity—Methotrexate—testicular cancer	0.000114	0.000328	CcSEcCtD
Aprepitant—Asthenia—Methotrexate—testicular cancer	0.000111	0.000319	CcSEcCtD
Aprepitant—Feeling abnormal—Doxorubicin—testicular cancer	0.00011	0.000318	CcSEcCtD
Aprepitant—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00011	0.000315	CcSEcCtD
Aprepitant—Pruritus—Methotrexate—testicular cancer	0.00011	0.000315	CcSEcCtD
Aprepitant—Hypersensitivity—Epirubicin—testicular cancer	0.000107	0.000307	CcSEcCtD
Aprepitant—Urticaria—Doxorubicin—testicular cancer	0.000106	0.000306	CcSEcCtD
Aprepitant—Body temperature increased—Doxorubicin—testicular cancer	0.000106	0.000305	CcSEcCtD
Aprepitant—Abdominal pain—Doxorubicin—testicular cancer	0.000106	0.000305	CcSEcCtD
Aprepitant—Diarrhoea—Methotrexate—testicular cancer	0.000106	0.000304	CcSEcCtD
Aprepitant—Asthenia—Epirubicin—testicular cancer	0.000104	0.000299	CcSEcCtD
Aprepitant—Pruritus—Epirubicin—testicular cancer	0.000102	0.000295	CcSEcCtD
Aprepitant—Dizziness—Methotrexate—testicular cancer	0.000102	0.000294	CcSEcCtD
Aprepitant—Diarrhoea—Epirubicin—testicular cancer	9.91e-05	0.000285	CcSEcCtD
Aprepitant—Hypersensitivity—Doxorubicin—testicular cancer	9.87e-05	0.000284	CcSEcCtD
Aprepitant—Vomiting—Methotrexate—testicular cancer	9.84e-05	0.000283	CcSEcCtD
Aprepitant—Rash—Methotrexate—testicular cancer	9.76e-05	0.000281	CcSEcCtD
Aprepitant—Dermatitis—Methotrexate—testicular cancer	9.75e-05	0.00028	CcSEcCtD
Aprepitant—Headache—Methotrexate—testicular cancer	9.7e-05	0.000279	CcSEcCtD
Aprepitant—Asthenia—Doxorubicin—testicular cancer	9.62e-05	0.000276	CcSEcCtD
Aprepitant—Dizziness—Epirubicin—testicular cancer	9.58e-05	0.000275	CcSEcCtD
Aprepitant—Pruritus—Doxorubicin—testicular cancer	9.48e-05	0.000273	CcSEcCtD
Aprepitant—Vomiting—Epirubicin—testicular cancer	9.21e-05	0.000265	CcSEcCtD
Aprepitant—Nausea—Methotrexate—testicular cancer	9.19e-05	0.000264	CcSEcCtD
Aprepitant—Diarrhoea—Doxorubicin—testicular cancer	9.17e-05	0.000264	CcSEcCtD
Aprepitant—Rash—Epirubicin—testicular cancer	9.13e-05	0.000263	CcSEcCtD
Aprepitant—Dermatitis—Epirubicin—testicular cancer	9.12e-05	0.000262	CcSEcCtD
Aprepitant—Headache—Epirubicin—testicular cancer	9.07e-05	0.000261	CcSEcCtD
Aprepitant—Dizziness—Doxorubicin—testicular cancer	8.86e-05	0.000255	CcSEcCtD
Aprepitant—Nausea—Epirubicin—testicular cancer	8.6e-05	0.000247	CcSEcCtD
Aprepitant—Vomiting—Doxorubicin—testicular cancer	8.52e-05	0.000245	CcSEcCtD
Aprepitant—Rash—Doxorubicin—testicular cancer	8.45e-05	0.000243	CcSEcCtD
Aprepitant—Dermatitis—Doxorubicin—testicular cancer	8.44e-05	0.000243	CcSEcCtD
Aprepitant—Headache—Doxorubicin—testicular cancer	8.4e-05	0.000241	CcSEcCtD
Aprepitant—Nausea—Doxorubicin—testicular cancer	7.96e-05	0.000229	CcSEcCtD
